Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Revolution Medicines (RVMD) Non Operating Income: 2018-2024

Historic Non Operating Income for Revolution Medicines (RVMD) over the last 7 years, with Dec 2024 value amounting to $88.7 million.

  • Revolution Medicines' Non Operating Income fell 48.19% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.3 million, marking a year-over-year decrease of 12.90%. This contributed to the annual value of $88.7 million for FY2024, which is 87.50% up from last year.
  • Per Revolution Medicines' latest filing, its Non Operating Income stood at $88.7 million for FY2024, which was up 87.50% from $47.3 million recorded in FY2023.
  • Revolution Medicines' Non Operating Income's 5-year high stood at $88.7 million during FY2024, with a 5-year trough of $917,000 in FY2021.
  • For the 3-year period, Revolution Medicines' Non Operating Income averaged around $48.4 million, with its median value being $47.3 million (2023).
  • Per our database at Business Quant, Revolution Medicines' Non Operating Income crashed by 57.68% in 2021 and then spiked by 898.26% in 2022.
  • Over the past 5 years, Revolution Medicines' Non Operating Income (Yearly) stood at $2.2 million in 2020, then plummeted by 57.68% to $917,000 in 2021, then surged by 898.26% to $9.2 million in 2022, then skyrocketed by 416.65% to $47.3 million in 2023, then spiked by 87.50% to $88.7 million in 2024.